[Intractable dermal lesions in the head and neck region].
Wirsching
K
K
Baumeister
P
P
Harréus
U
U
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000175:diagnosis; D015897:Comorbidity; D003299:Cooperative Behavior; D003937:Diagnosis, Differential; D018450:Disease Progression; D004359:Drug Therapy, Combination; D004630:Emergencies; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D033183:Interdisciplinary Communication; D008279:Magnetic Resonance Imaging; D010032:Otitis Externa / Q000175:diagnosis; D010038:Otorhinolaryngologic Diseases / Q000175:diagnosis* / Q000188:drug therapy; D017511:Pyoderma Gangrenosum / Q000175:diagnosis* / Q000188:drug therapy; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005938:Glucocorticoids; D000069285:Infliximab